Germ line mutation analysis in families with multiple endocrine neoplasia type 2A or familial medullary thyroid carcinoma

European Journal of Endocrinology

Volumn 139, Issue 4, 1998, Pages 410-415

  Karga, Helen J ^a   Karayianni, Maria K ^a   Linos, Dimitrios A ^b   Tseleni, Sofia C ^b   Karaiskos, Konstantine D ^a   Papapetrou, Peter D ^a  

^a ALEXANDRA HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AMYLOIDOSIS; ARTICLE; CANCER RISK; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DNA DETERMINATION; EARLY DIAGNOSIS; GENE MUTATION; GERM LINE; HUMAN; MEDULLARY CARCINOMA; PRIORITY JOURNAL; SCHOOL CHILD; SIPPLE SYNDROME; THYROID CARCINOMA;

ADOLESCENT; ADULT; AGED; CARCINOMA, MEDULLARY; CHILD; DNA MUTATIONAL ANALYSIS; FEMALE; GENOTYPE; GERM-LINE MUTATION; GREECE; HETEROZYGOTE DETECTION; HUMANS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SEQUENCE ANALYSIS, DNA; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 0031759421     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1390410     Document Type: Article

References (30)

1. Mulligan L, Kwok J, Healey C, Elsdon M, Eng C, Gardner E et al. Germ line mutations of the Ret proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993 363 458-460.
2. Donis-Keller H, Dou S, Chi D, Carlson KM, Tosinma K, Lairmore TC et al. Mutations in the Ret proto-oncogene are associated with MEN 2A and FMTC. Human Molecular Genetics 1993 2 851-856.
3. Hofstra RMW, Landsvater RM, Ceccherini I, Stulp RP, Steiwagen T, Luo Y et al. A mutation in the Ret proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 1994 367 375-376.
4. Durbec P, Marcos-Gutierrez C, Kilkenny C, Grigoriou M, Wartiowaara K, Suvanto P et al. GDNF signalling through the Ret receptor tyrosine kinase. Nature 1996 381 789-793.
5. Fantl W, Johnson D & William L. Signalling by receptor tyrosine kinases. Annual Review of Biochemistry 1993 62 453-481.
6. Donis-Keller H. The Ret proto-oncogene and cancer. Journal of Internal Medicine 1995 238 319-325.
7. Eng C, Clayton D, Schuffenecker I, Lenoir G, Cote G, Gagel R et al. The relationship between specific Ret proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. Journal of the American Medical Association 1996 276 1575-1579.
8. Hanks S, Qiunn AM & Hunter T. The protein kinase family: features and deduced phylogeny of the catalytic domains. Science 1988 241 42-52.
9. Ceccheziyi I, Romei C, Barone V, Paccini F, Martino E, Loviselli A et al. Identification of the Cys634→Tyr of the Ret proto-oncogene in a pedigree with multiple endocrine neoplasia type 2A and localized cutaneous lichen amyloidosis. Endocrinological Investigations 1994 17 201-204.
10. Mulligan L, Eng C, Attié T, Lyonner S, Marsh D, Hyland V et al. Diverse phenotypes associated with exon 10 mutations of the Ret proto-oncogene. Human and Molecular Genetics 1994 3 2163-2167.
11. Eng C. The Ret proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease. New England Journal of Medicine 1996 335 943-951.
12. Bolino A, Schuffenecker I, Luo V, Seri M, Sinengo M, Tocco T et al. Ret mutations in exons 13 and 14 of FMTC patients. Oncogene 1995 10 2415-2419.
13. Eng C, Smith DP, Mulligan LM, Healey CS, Zvelebil MJ, Stonehouse TJ et al. A novel point mutation in the tyrosine kinase domain of the Ret proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC. Oncogene 1995 10 509-513.
14. Smith DP, Houghton C & Ponder BA. Germline mutation of Ret codon 883 in two cases of de novo MEN 2B. Oncogene 1997 15 1213-1217.
15. Gimm O, Marsh D, Andrew S, Frilling A, Dahia P, Mulligan L et al. Germline dinucleotide mutation in codon 883 of the Ret protooncogene in multiple endocrine neoplasia type 2B without codon 918 mutation. Journal of Clinical Endocrinology and Metabolism 1997 82 3902-3904.
16. Mulligan L, Eng C, Healy C, Ponder M, Feldman G, Li P et al. A de novo mutation of the Ret proto-oncogene in a patient with MEN 2A. Human and Molecular Genetics 1994 3 1007-1008.
17. Wohlk N, Cote J, Bugalho M, Ordonez N, Evans D, Goepfert H et al. Relevance of Ret proto-oncogene mutations in sporadic medullary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 1996 81 3740-3745.
18. Schuffenecker I, Ginet N, Goldgar D, Eng C, Chambre B, Boneu A et al. Prevalence and parental origin of de novo Ret mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma. American Journal of Human Genetics 1997 60 233-237.
19. Quadro I, Panariello L, Salvatore D, Carlomagno F, Del Prete M, Nunziata V et al. Frequent Ret proto-oncogene mutations in multiple endocrine neoplasia type 2A. Journal of Clinical Endocrinology and Metabolism 1994 79 590-594.
20. Komminoth P, Kunz E, Hior O, Scroder S, Matias-Gutu X, Christiansen G et al. Detection of Ret proto-oncogene point mutations in paraffin-embedded pheochromocytoma specimens by nonradioactive single-strand conformation polymorphism analysis and direct sequencing. American Journal of Pathology 1994 145 922-929.
21. Tsai M, Ledger G, Khosla S, Gharib H & Thibodeau S. Identification of multiple endocrine neoplasia type 2 carriers using linkage analysis of the Ret proto-oncogene. Journal of Clinical Endocrinology and Metabolism 1994 78 1261-1264.
22. Santoro M, Carlomagno F, Romano A, Bottaro D, Dathan N, Grieco M et al. Activation of the RET as a dominant transforming gene by germline mutations of MEN 2A and MEN 2B. Nature 1995 267 381-383.
23. Fusco A, Grieco M, Santoro M, Berlingieri M, Pilotti S, Pierotti M et al. A new oncogene in human thyroid papillary carcinoma and their lymph-nodal metastases. Nature 1987 328 170-172.
24. Schuffenecker I, Billaud M, Calender A, Chambe B, Ginet N, Calmettes N et al. Ret proto-oncogene mutations in French MEN 2A and FMTC families. Human and Molecular Genetics 1994 3 1939-1943.
25. Raue KF, Hoppener W, Frilling A, Kotzerke J, Dralle H, Haase R et al. Mutations of the Ret proto-oncogene in German multiple endocrine neoplasia families: relation between genotype and phenotype. Journal of Clinical Endocrinology and Metabolism 1996 81 1780-1783.
26. Raue KF, Kratt T, Hoppner W, Buhr H, Ziegler R & Raue F. Diagnosis and management of pheochromocytomas in patients with multiple endocrine neoplasia type 2 - relevance of specific mutations in the Ret proto-oncogene. European Journal of Endocrinology 1996 135 222-225.
27. Shuffenecker I, Virally-Monod M, Brohet B, Goldgat D, Contex-Devolx B, Leclerc L et al. Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Journal of Clinical Endocrinology and Metabolism 1998 83 487-491.
28. 3 of transcription of the bovine parathyroid hormone gene. Endocrinology 1995 117 2114-2116.
29. Pachnis V, Mankoo B & Constantini F. Expression of the c-ret proto-oncogene during mouse embryogenesis. Development 1993 119 1005-1017.
30. Gagel R, Levy M, Donovan D, Alford B, Wheeler T & Tschen J. Multiple endocrine neoplasia type 2A associated with cutaneous lichen amyloidosis. Annals of Internal Medicine 1989 111 802-806.